Quick Order Cart

Cat. No. ARG1578

PANK2 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The PANK2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of Raji B lymphocytes, featuring disrupted PANK2 expression to abolish mitochondrial pantothenate kinase 2 activity. This ablation removes the rate-limiting step in coenzyme A (CoA) biosynthesis, impairing downstream production of acetyl-CoA and mitochondrial respiration, with regulatory inputs from mTORC1 and feedback inhibition by CoA/acetyl-CoA. This model enables investigation of CoA deficiency in B-cell metabolism, pantothenate kinase-associated neurodegeneration (PKAN), and mitochondrial dysfunction. It supports screening for CoA-restoring compounds and studies of lipid peroxidation and iron homeostasis, utilizing assays such as Seahorse analysis and Perls' iron staining.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    PANK2

    Gene Identifier

    NCBI Gene ID 80025

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The PANK2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from Raji B lymphocytes, with targeted disruption of the PANK2 gene. This loss-of-function model eliminates mitochondrial pantothenate kinase 2, enabling investigation of CoA biosynthesis deficiency without monoclonal selection.

Raji cells, an EBV-positive Burkitt lymphoma line, serve as a widely used model for B-cell functions and oncogenesis. The integration of PANK2 knockout into this immortalized background allows interrogation of metabolic pathways within malignant B lymphocytes, expanding studies of PKAN-related mitochondrial dysfunction to a hematological context.

PANK2 catalyzes the rate-limiting phosphorylation of pantothenate to 4′-phosphopantothenate in mitochondrial CoA synthesis. It is regulated by insulin/IGF-1, mTORC1, PPARA, and feedback inhibition by CoA/acetyl-CoA, and interacts with COASY, PPCS, cardiolipin, and NCLX, forming homodimers. Downstream targets include CoA, acetyl-CoA, succinyl-CoA, propionyl-CoA, and mitochondrial respiratory chain complexes, linking to TCA cycle and histone acetylation. PANK2 disruption impairs CoA production, fatty acid oxidation, and oxidative phosphorylation, promoting mitochondrial dysfunction, oxidative stress, and iron dyshomeostasis reminiscent of PKAN.

In Raji B cells, PANK2 knockout affects energy metabolism and CoA-dependent processes, offering a tool to study B-cell metabolism, lymphoma biology, and neurodegeneration mechanisms. The model exhibits iron accumulation and lipid peroxidation, measurable by Perls’ staining and C11-BODIPY, mimicking PKAN pathology and enabling translational research in a non-neuronal system, while also elucidating metabolic reprogramming in lymphoma.

Applications include elucidating CoA deficiency in B cells, modeling PKAN, screening small molecules to restore CoA, studying lipid metabolism and oxidative stress in lymphoma, and investigating mitophagy and ferroptosis. Assays encompass Western blotting, RT-qPCR, LC-MS for CoA/acetyl-CoA, Seahorse respiration, Perls’ staining, C11-BODIPY, TMRE flow cytometry, apoptosis detection, and viability under pantothenate deprivation. Contact Ascent Research for details.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)